๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck

โœ Scribed by Fred Rosen; Everett E. Vokes; Thomas Lad; Merrill Kies; James Wade; Lary J. Kilton; Richard Blough; Suzanne French; Michael Mullane; Al. B. Benson

Publisher
Springer US
Year
1995
Tongue
English
Weight
299 KB
Volume
13
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II study of mitoxantrone in advanc
Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck
โœ Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer US ๐ŸŒ English โš– 170 KB

A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap

Efficacy of neck treatment in patients w
Efficacy of neck treatment in patients with head and neck squamous cell carcinoma
โœ Gabriela Buck; Pia Huguenin; Sandro J. Stoeckli ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 2 views

## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the